Browse the complete record of transactions filed by 胡坤, Director. Insider active across 1 company, notably 康泰医学. In total, 29 filings have been published. History available since 15 November 2024. The latest transaction was disclosed on 14 November 2025 (Sale). Regulator: SSE / SZSE (CSRC). All data is accessible without signup.
Companies and markets linked to 胡坤
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Hu Kun is a Director of 康泰医学, where he contributes to the governance and strategy of the company. His expertise in the medical field allows him to provide unique insights into strategic decisions.